Leonid Timashev
Stock Analyst at RBC Capital
(4.91)
# 241
Out of 5,020 analysts
511
Total ratings
61.7%
Success rate
24.4%
Average return
Main Sectors:
Stocks Rated by Leonid Timashev
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics | Maintained: Buy | $59 | $44.51 | +32.55% | 43 | Sep 23, 2026 | |
| ALKS Alkermes | Reiterated: Buy | $56 | $43.29 | +29.36% | 23 | Sep 22, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $297 | $203.10 | +46.23% | 41 | Sep 18, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $251 | $192.86 | +30.15% | 15 | Sep 16, 2026 | |
| VSTM Verastem | Reiterated: Buy | $14 | $8.37 | +67.26% | 16 | Sep 16, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $112 | $67.59 | +65.70% | 26 | Sep 10, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $287 | $269.19 | +6.62% | 1 | Sep 9, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $58 | $18.64 | +211.16% | 47 | Sep 9, 2026 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $5 → $6 | $3.36 | +78.84% | 19 | Sep 9, 2026 | |
| BHVN Biohaven | Downgraded: Hold | $23 → $19 | $14.85 | +27.95% | 32 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $273 → $299 | $240.57 | +24.29% | 15 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 | $120.82 | +61.40% | 26 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 | $368.08 | +22.26% | 17 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.23 | +62.60% | 18 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $14 | $7.78 | +79.95% | 16 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.96 | +372.97% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $79 | $77.74 | +1.62% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $58.15 | -20.89% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $19 → $20 | $6.10 | +227.87% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $449 → $462 | $300.65 | +53.67% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 → $21 | $14.78 | +42.08% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $50 | $23.32 | +114.41% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $20 | $25.16 | -20.51% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $39.71 | +20.88% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.16 | +51.98% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $3.73 | +34.05% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.6229 | +381.62% | 7 | May 14, 2026 |
Edgewise Therapeutics
Sep 23, 2026
Maintained: Buy
Price Target: $59
Current: $44.51
Upside: +32.55%
Alkermes
Sep 22, 2026
Reiterated: Buy
Price Target: $56
Current: $43.29
Upside: +29.36%
Axsome Therapeutics
Sep 18, 2026
Reiterated: Buy
Price Target: $297
Current: $203.10
Upside: +46.23%
Revolution Medicines
Sep 16, 2026
Reiterated: Buy
Price Target: $251
Current: $192.86
Upside: +30.15%
Verastem
Sep 16, 2026
Reiterated: Buy
Price Target: $14
Current: $8.37
Upside: +67.26%
Cytokinetics
Sep 10, 2026
Reiterated: Buy
Price Target: $112
Current: $67.59
Upside: +65.70%
Johnson & Johnson
Sep 9, 2026
Reiterated: Buy
Price Target: $287
Current: $269.19
Upside: +6.62%
Legend Biotech
Sep 9, 2026
Reiterated: Buy
Price Target: $58
Current: $18.64
Upside: +211.16%
Pyxis Oncology
Sep 9, 2026
Reiterated: Buy
Price Target: $5 → $6
Current: $3.36
Upside: +78.84%
Biohaven
Sep 8, 2026
Downgraded: Hold
Price Target: $23 → $19
Current: $14.85
Upside: +27.95%
Aug 28, 2026
Reiterated: Buy
Price Target: $273 → $299
Current: $240.57
Upside: +24.29%
Aug 25, 2026
Reiterated: Buy
Price Target: $195
Current: $120.82
Upside: +61.40%
Aug 25, 2026
Reiterated: Buy
Price Target: $450
Current: $368.08
Upside: +22.26%
Aug 13, 2026
Reiterated: Hold
Price Target: $2
Current: $1.23
Upside: +62.60%
Aug 13, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $7.78
Upside: +79.95%
Aug 10, 2026
Reiterated: Buy
Price Target: $14
Current: $2.96
Upside: +372.97%
Aug 6, 2026
Reiterated: Buy
Price Target: $81 → $79
Current: $77.74
Upside: +1.62%
Aug 6, 2026
Reiterated: Hold
Price Target: $46
Current: $58.15
Upside: -20.89%
Aug 6, 2026
Rated: Buy
Price Target: $19 → $20
Current: $6.10
Upside: +227.87%
Aug 6, 2026
Rated: Buy
Price Target: $449 → $462
Current: $300.65
Upside: +53.67%
Aug 5, 2026
Rated: Buy
Price Target: $22 → $21
Current: $14.78
Upside: +42.08%
Aug 5, 2026
Reiterated: Buy
Price Target: $51 → $50
Current: $23.32
Upside: +114.41%
Aug 5, 2026
Reiterated: Buy
Price Target: $19 → $20
Current: $25.16
Upside: -20.51%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $39.71
Upside: +20.88%
Aug 3, 2026
Reiterated: Buy
Price Target: $20
Current: $13.16
Upside: +51.98%
Jul 30, 2026
Reiterated: Hold
Price Target: $5
Current: $3.73
Upside: +34.05%
May 14, 2026
Reiterated: Hold
Price Target: $4 → $3
Current: $0.6229
Upside: +381.62%